Risankizumab in severe asthma: A Phase IIa, placebo-controlled study

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Brightling, Christopher E.; Nair, Parameswaran; Louis, Renaud; Singh, Dave

Journal title: Airway pharmacology and treatment

Journal number: 1

Journal publisher: European Respiratory Society

Published year: 2020

DOI identifier: 10.1183/13993003.congress-2020.3699